NEW YORK, April 18, 2013 (GLOBE NEWSWIRE) -- Immudyne, Inc. (OTCQB:IMMD) announced today that the company plans to execute a 15-Month Sales and Marketing Plan to accomplish increased revenue growth. The company will hold a conference call on Thursday, April 25th at 11 a.m. EDT. To participate in the call, please dial 1-800-816-4164. When prompted, enter the GUEST CODE of 636174#
Afterwards, a recording of the call will be available for listening by visiting immudyne.com/IR.
The company also released today a new corporate presentation outlining management's vision. The presentation can be found at http://www.immudyne.com/pages/investors-1
Highlights of the plan include rebranding the company with a new strategic focus, introducing new product lines, and expanding into new multi-billion dollar US markets.
Karen Kingston, Chief Marketing Officer, stated, "There are many internal and external factors that weaken our immune system, some of which are lifestyle decisions. Our product helps support the immune system even when consumers engage in lifestyle choices that suppress their innate immune response. Our product is a dietary supplement supported by excellent clinical data and consumer experience that has the potential to benefit millions of people within the United States immediately. We have developed a strategic marketing plan that we believe we can execute cost-effectively in order spread our message to millions of target customers."
Mark McLaughlin, President & CEO, stated, "We believe Immudyne's new strategic focus will result in accelerated revenue growth for the company. We plan to launch new product lines in several multi-billion dollar US markets that we have not targeted before. We also plan to expand our board of directors over the next year to strengthen our expert knowledge and create new strategic alliances."
Immudyne is a health and wellness lifestyle company. Immudyne has a portfolio of unique patent-protected products with applications in the wellness lifestyle, skin care, anti-aging, fitness, and health markets. Immudyne has offices located in Mt. Kisco, NY, Carlsbad, CA, and Florence, Kentucky.
Immudyne shares trade under the ticker symbol IMMD and the Company can be found on the web at www.immudyne.com.
Cautionary language regarding Forward-Looking Statements Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "projects," "plans," "targets" and other similar language and are considered forward-looking statements. These statements are based on management's current expectations, estimates, and forecasts. These forward-looking statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and therefore the actual results may be materially different from those discussed.
CONTACT: Immudyne, Inc. Mark McLaughlin +1-914-714-8901 MarkMcL@immudyne.comSource:Immudyne, Inc.